Related Experiment Video
Updated: Jun 14, 2026

06:15
Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
Plateau Iris Configuration and Dark-Light Changes in Anterior Segment Optical Coherence Tomography
Summary
Angle opening distance (AOD) measurements using anterior segment optical coherence tomography (ASOCT) reveal significant dark-light changes in convex iris configuration (CIC) but not plateau iris configuration (PIC). ASOCT can differentiate between CIC and PIC based on these dynamic anterior chamber angle changes.
Area of Science:
- Ophthalmology
- Anatomical imaging
- Optometry
Background:
- Iris configuration variations, such as convex iris configuration (CIC) and plateau iris configuration (PIC), can influence anterior chamber dynamics.
- Understanding these dynamics under different lighting conditions is crucial for diagnosing and managing certain ocular conditions.
Purpose of the Study:
- To investigate the effect of dark-light conditions on angle opening distance (AOD) in patients with CIC and PIC.
- To determine if AOD measurements using anterior segment optical coherence tomography (ASOCT) can differentiate between CIC and PIC based on dynamic changes.
Main Methods:
- Anterior segment optical coherence tomography (ASOCT) was employed to measure AOD in 14 CIC and 12 PIC patients.
- Measurements were taken under both dark and bright light conditions, focusing on nasal quadrants.
- Statistical analysis (P-values) was used to assess the significance of changes in AOD.
Main Results:
- Convex iris configuration (CIC) showed statistically significant changes in AOD (AOD500, P = .025; AOD750, P = .000) between dark and bright conditions in the nasal quadrant.
- Plateau iris configuration (PIC) did not exhibit significant dynamic changes in AOD under varying light conditions (AOD500, P = .38).
- AOD parameters derived from ASOCT effectively demonstrated differential responses to light changes between CIC and PIC.
Conclusions:
- ASOCT-derived AOD parameters are valuable for analyzing anterior chamber angle alterations in response to light variations.
- These dynamic changes can serve as a key differentiator between convex iris configuration (CIC) and plateau iris configuration (PIC).
- The study highlights the utility of ASOCT in characterizing iris morphologic subtypes based on their response to environmental light stimuli.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...

